John & Jean Piety Named SLA Engineering Lib...
NEW YORK, June 23 /PRNewswire/ --
- Special Library Association (SLA) and Elsevier's Engineering and
Technology Division Celebrate the 40th Anniversary of SLA and Honor Two
Lifetimes of Achievement
Elsevier's Engineering and Technology Division today
congratulated John and Jean Piety on being this year's recipients of the
Special Library Association's (SLA) Engineering Division Librarians of the
Year Award. Mr. and Mrs. Piety's contributions to the SLA Engineering
Division include exceptional performance while holding a variety of positions
within SLA.
Jean has been a member of SLA since 1958, thus celebrating her
50th anniversary this year, while John has been a member since 1975. SLA
lists Jean as having held Cleveland Chapter positions as Networking Chair,
President-Elect & President.
John has served as Bulletin Editor, President-Elect and
President of the Cleveland Chapter, Membership Chair, Chair-Elect and Chair
of the IT Division of SLA and has served on the Bylaws Committee for the
Association.
Sponsored by Elsevier's Engineering and Technology Division,
the 14th annual award includes a certificate of achievement and a $1,500
stipend. It was presented to Mr. and Mrs. Piety during the Engineering
Division Award's Luncheon at the 40th Annual SLA annual conference in
Seattle, WA on June 15th.
Deborah Jordan, Director of Marketing for Elsevier's
Engineering and Technology Division, congratulated the winners by stating,
"Jean and John Piety are to be congratulated for their commitment to both
the
SLA and the engineering community."
Presented annually to recognize contributions to the
engineering librarian profession, recipients are nominated by their peers and
selected via the SLA Engineering Division Awards Committee.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as Science Direct. (http://www.sciencedirect.com/), MDConsult
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business
headquartered in Amsterdam, The Netherlands and has offices worldwide.
Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a
world-leading publisher and information provider. Operating in the science
and medical, legal, education and business-to-business sectors, Reed Elsevier
provides high-quality and flexible information solutions to users, with
increasing emphasis on the Internet as a means of delivery. Reed Elsevier's
ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK
and ENL (New York Stock Exchange).
Contact:
Alicia Burns
E&T Marketing
a.burns@elsevier.com
+1-212-633-3722
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.